GO:0004494 methylmalonyl-CoA mutase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004494 methylmalonyl-CoA mutase activity is a catalytic activity that converts methylmalonyl-CoA to succinyl-CoA, a key step in propionate metabolism.
• The enzyme requires adenosylcobalamin (vitamin B12) as a cofactor for its radical-based catalytic mechanism.
• Deficiency of methylmalonyl-CoA mutase activity causes isolated methylmalonic acidemia, a severe inherited metabolic disorder.
• The enzyme is inhibited by various CoA-esters, and its activity can be derailed by itaconyl-CoA, which forms a stable biradical.
• Methylmalonyl-CoA mutase is studied using knockout cell models, proteomics, and enzymatic assays to understand its role in metabolism and disease.
• Research on this activity informs therapeutic strategies for methylmalonic acidemia and related metabolic conditions.
Description
Methylmalonyl-CoA mutase activity (GO:0004494) is a fundamental enzymatic activity in cellular metabolism, catalyzing the reversible isomerization of methylmalonyl-CoA to succinyl-CoA. This reaction is a critical step in the breakdown of odd-chain fatty acids, cholesterol, and certain amino acids, linking these pathways to the tricarboxylic acid cycle. The enzyme belongs to the class of isomerases and requires adenosylcobalamin, a derivative of vitamin B12, to perform its catalytic function through a radical mechanism. Researchers study this activity to understand metabolic disorders, mitochondrial dysfunction, and the broader implications of vitamin B12 biology. The importance of methylmalonyl-CoA mutase activity extends beyond basic metabolism. Inherited mutations in the MUT gene, which encodes the enzyme, lead to isolated methylmalonic acidemia, a life-threatening condition characterized by accumulation of methylmalonic acid and metabolic decompensation. Additionally, the enzyme is a target of inhibition by various CoA-esters and can be inactivated by itaconyl-CoA, a metabolite involved in immune responses. These findings highlight the enzyme's vulnerability to metabolic perturbations and its relevance in disease contexts. Understanding its regulation and dysfunction is essential for developing therapeutic interventions.
methylmalonyl-CoA mutase activity At A Glance
| GO ID | GO:0004494 |
|---|---|
| GO term | methylmalonyl-CoA mutase activity |
| Ontology | biological_process |
| Synonym | None |
| Major function | Catalyzes the conversion of methylmalonyl-CoA to succinyl-CoA in propionate metabolism |
| Cofactor | Adenosylcobalamin (vitamin B12 derivative) |
| Subcellular location | Mitochondrial matrix |
| EC number | 5.4.99.2 |
| Pathway | Propanoate metabolism, valine/leucine/isoleucine degradation |
What Is GO:0004494?
Methylmalonyl-CoA mutase activity (GO:0004494) is defined as the catalysis of the reversible conversion of methylmalonyl-CoA to succinyl-CoA. This isomerization reaction involves the intramolecular rearrangement of a carbon skeleton and requires adenosylcobalamin as a cofactor. The activity is essential for propionate catabolism and is localized primarily in mitochondria.
Why Is methylmalonyl-CoA mutase activity Important in Cell Biology?
Methylmalonyl-CoA mutase activity is indispensable for normal metabolic homeostasis, as it funnels propionate-derived carbon into the TCA cycle. Its dysfunction results in methylmalonic acidemia, a disorder with severe clinical manifestations including metabolic acidosis, developmental delay, and organ failure. The enzyme's reliance on vitamin B12 connects it to nutritional status, and its inhibition by metabolites like itaconyl-CoA links it to immune-metabolic crosstalk. Thus, understanding this activity is crucial for diagnosing and treating metabolic diseases and for deciphering mitochondrial energy metabolism.
• Deficiency causes isolated methylmalonic acidemia, a severe inherited metabolic disorder.
• It is a key enzyme in propionate metabolism, affecting energy production.
• Requires vitamin B12, linking nutrition to metabolic health.
• Inhibited by various CoA-esters, impacting metabolic flux.
• Targeted by itaconyl-CoA, connecting immunity and metabolism.
• Studied in neuroblastoma models to understand metabolic reprogramming.
• Its activity can be measured enzymatically for diagnostic purposes.
• Mouse models provide insights into enzyme structure and function.
• Potential target for therapies in metabolic disorders.
• Relevant to mitochondrial dysfunction and oxidative stress.
What Happens During methylmalonyl-CoA mutase activity?
Substrate Binding and Radical Initiation
In simple terms: The enzyme grabs its substrate and a vitamin B12 molecule to start a chemical reaction.
Methylmalonyl-CoA mutase binds methylmalonyl-CoA and adenosylcobalamin in its active site. The cobalt-carbon bond of adenosylcobalamin undergoes homolytic cleavage to generate a 5'-deoxyadenosyl radical, which abstracts a hydrogen atom from the substrate to form a substrate radical.
Carbon Skeleton Rearrangement
In simple terms: The substrate's atoms rearrange to form a new molecule.
The substrate radical undergoes a 1,2-shift of the carbonyl-CoA group, converting methylmalonyl-CoA to succinyl-CoA radical. This rearrangement is facilitated by the enzyme's active site architecture, which stabilizes the radical intermediate.
Radical Quenching and Product Release
In simple terms: The reaction finishes, and the new molecule is released.
The succinyl-CoA radical abstracts a hydrogen atom from 5'-deoxyadenosine, regenerating the adenosyl radical and forming succinyl-CoA. The product is then released, and the enzyme is ready for another cycle.
Inhibition and Inactivation
In simple terms: Certain molecules can block or break the enzyme.
Various CoA-esters, such as propionyl-CoA and succinyl-CoA, inhibit methylmalonyl-CoA mutase activity. Additionally, itaconyl-CoA forms a stable biradical that derails catalysis and impairs enzyme repair, leading to inactivation.
Key Genes Involved in GO:0004494 methylmalonyl-CoA mutase activity
The following genes and proteins are central to methylmalonyl-CoA mutase activity and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MUT | Encodes methylmalonyl-CoA mutase | Mutations cause methylmalonic acidemia |
| MMAA | GTPase involved in cofactor delivery | Mutations cause methylmalonic acidemia |
| MMAB | ATP:cob(I)alamin adenosyltransferase | Mutations cause methylmalonic acidemia |
| MMACHC | Cobalamin processing | Mutations cause combined methylmalonic acidemia and homocystinuria |
| MMADHC | Cobalamin trafficking | Mutations cause methylmalonic acidemia |
| MCEE | Methylmalonyl-CoA epimerase | Converts D-methylmalonyl-CoA to L-form |
| PCCA | Propionyl-CoA carboxylase alpha subunit | Mutations cause propionic acidemia |
| PCCB | Propionyl-CoA carboxylase beta subunit | Mutations cause propionic acidemia |
| ACADM | Medium-chain acyl-CoA dehydrogenase | Related to fatty acid oxidation |
| HADHA | Mitochondrial trifunctional protein alpha | Fatty acid oxidation |
| HADHB | Mitochondrial trifunctional protein beta | Fatty acid oxidation |
| SUCLA2 | Succinyl-CoA ligase beta | Links to TCA cycle |
| SUCLG1 | Succinyl-CoA ligase alpha | Links to TCA cycle |
| CLYBL | Citrate lyase beta-like | Itaconyl-CoA metabolism |
| ACOT8 | Acyl-CoA thioesterase 8 | CoA ester metabolism |
| SLC25A10 | Mitochondrial dicarboxylate carrier | Transport of metabolites |
| SLC25A11 | Mitochondrial oxoglutarate carrier | Transport of metabolites |
| SLC25A1 | Mitochondrial citrate carrier | Transport of metabolites |
How Is methylmalonyl-CoA mutase activity Regulated?
Methylmalonyl-CoA mutase activity is regulated at multiple levels. Its expression is influenced by vitamin B12 status, as the cofactor is essential for activity. The enzyme's activity can be inhibited by feedback from downstream metabolites such as succinyl-CoA and other CoA-esters. Additionally, itaconyl-CoA, produced by immune cells, covalently modifies the enzyme and impairs its function, linking regulation to immune responses. The enzyme also undergoes repair by a dedicated system involving MMAA and MMAB, which maintain cofactor integrity.
methylmalonyl-CoA mutase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MUT | Isolated methylmalonic acidemia | MUT knockout cell lines, patient-derived fibroblasts |
| MMAA | Methylmalonic acidemia with cofactor deficiency | MMAA knockout HEK293 cells |
| MMAB | Methylmalonic acidemia | MMAB knockout hepatocytes |
| MMACHC | Combined methylmalonic acidemia and homocystinuria | MMACHC knockout fibroblasts |
| CLYBL | Itaconyl-CoA metabolism | CLYBL overexpression in macrophages |
Isolated Methylmalonic Acidemia
Mutations in the MUT gene or genes involved in cobalamin metabolism (MMAA, MMAB, MMACHC, MMADHC) lead to isolated methylmalonic acidemia, characterized by accumulation of methylmalonic acid, metabolic acidosis, and multi-organ failure. The severity depends on residual enzyme activity, with complete loss causing early-onset severe disease.
Neurodegeneration and Metabolic Encephalopathy
Chronic methylmalonic acidemia often presents with neurological complications, including developmental delay, seizures, and basal ganglia stroke. These are thought to result from mitochondrial dysfunction and energy failure due to impaired methylmalonyl-CoA mutase activity.
Itaconyl-CoA-Mediated Inactivation in Immunity
Itaconyl-CoA, an antimicrobial metabolite produced by macrophages, forms a stable biradical with methylmalonyl-CoA mutase, inhibiting its activity. This links the enzyme to host defense and immune-metabolic regulation.
From methylmalonyl-CoA mutase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Enzyme kinetics and cofactor binding | Recombinant MUT overexpression in E. coli |
| Metabolic consequences of loss of function | MUT knockout HEK293 or HepG2 cells |
| Cofactor trafficking and repair | MMAA/MMAB knockout cell lines |
| Itaconyl-CoA inhibition | MUT knock-in with point mutations in active site |
| Neuroblastoma metabolic reprogramming | MUT-silenced neuroblastoma cell line |
| In vivo disease modeling | Mut knockout mouse |
How to Study the methylmalonyl-CoA mutase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic assay | Conversion of methylmalonyl-CoA to succinyl-CoA | Diagnosis of methylmalonic acidemia |
| LC-MS/MS | Methylmalonic acid levels | Metabolic profiling |
| Western blot | Protein expression of MUT and partners | Validation of knockout efficiency |
| Proteomics | Global protein changes | Pathway analysis in silenced cells |
| CRISPR knockout | Gene function loss | Disease modeling |
| Site-directed mutagenesis | Specific amino acid roles | Structure-function studies |
| Mouse models | In vivo phenotype | Preclinical testing |
Enzymatic Activity Assays
Methylmalonyl-CoA mutase activity is measured using spectrophotometric or radiometric assays that monitor the conversion of methylmalonyl-CoA to succinyl-CoA. These assays require adenosylcobalamin and are used for diagnosis of methylmalonic acidemia.
Proteomics and Metabolomics
Label-free quantitative proteomics can assess protein expression changes in MUT-silenced cells, while metabolomics quantifies methylmalonic acid and related metabolites to evaluate pathway flux.
Western Blotting and Immunodetection
Western blotting with antibodies against MUT, MMAA, and MMAB is used to assess protein levels and post-translational modifications in cell and tissue samples.
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 is used to generate knockout cell lines for MUT and related genes to study loss-of-function phenotypes and validate disease mechanisms.
How CRISPR Can Be Used to Study GO:0004494 methylmalonyl-CoA mutase activity
Knockout
CRISPR-Cas9 knockout of MUT or related genes (MMAA, MMAB) in cell lines such as HEK293 or HepG2 creates models of methylmalonic acidemia. These knockouts exhibit reduced enzyme activity and accumulate methylmalonic acid, mimicking patient phenotypes.
Point Mutation
Introducing specific point mutations (e.g., in the active site of MUT) via CRISPR base editing or HDR allows researchers to study the impact on catalytic activity and cofactor binding, providing insights into disease-causing mutations.
Knock-in
Knock-in of tagged MUT (e.g., FLAG or GFP) enables affinity purification and imaging of the enzyme in live cells, facilitating studies on localization, interactions, and dynamics.
Overexpression
Overexpression of wild-type or mutant MUT in cell lines is used to produce recombinant enzyme for biochemical assays and to study dominant-negative effects.
How EDITGENE Supports methylmalonyl-CoA mutase activity Research
Researchers studying methylmalonyl-CoA mutase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic pathways or disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for methylmalonyl-CoA mutase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| MMUT Knockout HEK293 Cell Line | EDJ-KQ5274 | Human | 4594 | Details Get a Quote |
| MMUT Knockout A-549 Cell Line | EDJ-KQ28321 | Human | 4594 | Details Get a Quote |
| MMUT Knockout HCT 116 Cell Line | EDJ-KQ28322 | Human | 4594 | Details Get a Quote |
| MMUT Knockout HeLa Cell Line | EDJ-KQ28323 | Human | 4594 | Details Get a Quote |
| MMUT Knockout HAP1 Cell Line | EDC07981 | Human | 4594 | Details Get a Quote |
Displaying Records 1 To 5 Of 5 Records
Frequently Asked Questions About methylmalonyl-CoA mutase activity
What is methylmalonyl-CoA mutase activity?
Methylmalonyl-CoA mutase activity (GO:0004494) is the catalytic conversion of methylmalonyl-CoA to succinyl-CoA, a key step in propionate metabolism, requiring vitamin B12.
What genes are involved in methylmalonyl-CoA mutase activity?
The primary gene is MUT, which encodes the enzyme. Other genes include MMAA, MMAB, MMACHC, and MMADHC, which are involved in cofactor metabolism and repair.
What diseases are associated with methylmalonyl-CoA mutase deficiency?
Deficiency causes isolated methylmalonic acidemia, a severe metabolic disorder with symptoms like acidosis, developmental delay, and organ failure.
How is methylmalonyl-CoA mutase activity regulated?
It is regulated by vitamin B12 availability, feedback inhibition by CoA-esters, and inactivation by itaconyl-CoA.
What is the role of vitamin B12 in methylmalonyl-CoA mutase activity?
Vitamin B12, in the form of adenosylcobalamin, is an essential cofactor that enables the radical-based catalytic mechanism.
Can methylmalonyl-CoA mutase activity be measured in the lab?
Yes, enzymatic assays using spectrophotometry or radiometry can measure the conversion of methylmalonyl-CoA to succinyl-CoA.
What are the research models for methylmalonyl-CoA mutase deficiency?
Knockout cell lines (e.g., MUT knockout HEK293) and mouse models are commonly used to study the deficiency.
How does itaconyl-CoA affect methylmalonyl-CoA mutase?
Itaconyl-CoA forms a stable biradical with the enzyme, inhibiting its activity and impairing repair mechanisms.
What is the subcellular localization of methylmalonyl-CoA mutase?
The enzyme is localized in the mitochondrial matrix.
What are the therapeutic approaches for methylmalonic acidemia?
Treatment includes dietary restriction, carnitine supplementation, and in severe cases, organ transplantation. Gene therapy is under investigation.
Conclusion
Methylmalonyl-CoA mutase activity (GO:0004494) is a cornerstone of propionate metabolism, with critical roles in energy homeostasis and disease. Its dysfunction leads to methylmalonic acidemia, and its regulation is tightly linked to vitamin B12 and metabolic signals. Continued research using CRISPR models and advanced omics will unravel new therapeutic opportunities.
References
- 1. Takahashi-Iñiguez T et al.. 2012. Role of vitamin B12 on methylmalonyl-CoA mutase activity.. J Zhejiang Univ Sci B 13(6):423-37 PMID: 22661206
- 2. Mascarenhas R et al.. 2022. Human B(12)-dependent enzymes: Methionine synthase and Methylmalonyl-CoA mutase.. Methods Enzymol 668:309-326 PMID: 35589199
- 3. Adam MP et al.. 1993. Isolated Methylmalonic Acidemia.. PMID: 20301409
- 4. Taoka S et al.. 1994. Inhibition of the human methylmalonyl-CoA mutase by various CoA-esters.. J Biol Chem 269(50):31630-4 PMID: 7989334
- 5. Wilkemeyer MF et al.. 1990. Primary structure and activity of mouse methylmalonyl-CoA mutase.. Biochem J 271(2):449-55 PMID: 1978672
- 6. Costanzo M et al.. 2018. Label-Free Quantitative Proteomics in a Methylmalonyl-CoA Mutase-Silenced Neuroblastoma Cell Line.. Int J Mol Sci 19(11) PMID: 30428564
- 7. Herrmann W et al.. 2012. Cobalamin deficiency.. Subcell Biochem 56:301-22 PMID: 22116706
- 8. Ruetz M et al.. 2019. Itaconyl-CoA forms a stable biradical in methylmalonyl-CoA mutase and derails its activity and repair.. Science 366(6465):589-593 PMID: 31672889
